Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Testosterone's muscle-building effects do not require its conversion to DHT.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Some common medications can harm male fertility, but many effects can be reversed.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Certain drugs that block specific enzymes can help treat prostate diseases.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.